Re: The Natural History of Untreated Biopsy Grade Group Progression and Delayed Definitive Treatment for Men on Active Surveillance for Early-stage Prostate Cancer

被引：0
|
作者：
Turkeri, Levent [1 ]
Ozen, Haluk [2 ]
机构：
[1] Acibadem MA Aydinlar Univ, Dept Urol, Istanbul, Turkiye
[2] Hacettepe Univ, Dept Urol, Ankara, Turkiye
来源：
EUROPEAN UROLOGY | 2023年 / 83卷 / 03期
关键词：
D O I：
10.1016/j.eururo.2022.12.005
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：296 / 296
页数：1
相关论文
共 50 条
  • [41] Disease insight and treatment perception of men on active surveillance for early prostate cancer
    van den Bergh, Roderick C. N.
    van Vugt, Heidi A.
    Korfage, Ida J.
    Steyerberg, Ewout W.
    Roobol, Monique J.
    Schroder, Fritz H.
    Essink-Bot, Marie-Louise
    BJU INTERNATIONAL, 2010, 105 (03) : 322 - 328
  • [42] Predictors of Pathologic Progression on Biopsy Among Men on Active Surveillance for Localized Prostate Cancer: The Value of the Pattern of Surveillance Biopsies
    Cary, K. Clint
    Cowan, Janet E.
    Sanford, Melissa
    Shinohara, Katsuto
    Perez, Nannette
    Chan, June M.
    Meng, Maxwell V.
    Carroll, Peter R.
    EUROPEAN UROLOGY, 2014, 66 (02) : 337 - 342
  • [43] Impact of a negative confirmatory biopsy on risk of disease progression among men on active surveillance for prostate cancer
    Salari, Keyan
    Kowitz, Jason
    Twum-Ampofo, Jeffrey
    Gusev, Andrew
    O'Shea, Aileen
    Anderson, Mark A.
    Harisinghani, Mukesh
    Kuppermann, David
    Dahl, Douglas M.
    Efstathiou, Jason A.
    Lee, Richard J.
    Blute, Michael L.
    Zietman, Anthony L.
    Feldman, Adam S.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2023, 41 (09) : 387.e9 - 387.e16
  • [44] Re: Treatment in the Absence of Disease Reclassification among Men on Active Surveillance for Prostate Cancer
    不详
    JOURNAL OF UROLOGY, 2022, 207 (02): : 468 - 468
  • [45] Identifying Men Who Can Remain on Active Surveillance Despite Biopsy Reclassification to Grade Group 2 Prostate Cancer EDITORIAL COMMENT
    Prasad, Sandip M.
    Kovac, Evan
    JOURNAL OF UROLOGY, 2023, 210 (01): : 107 - 107
  • [46] Dietary Patterns and Risk of Gleason Grade Progression among Men on Active Surveillance for Prostate Cancer: Results from the Canary Prostate Active Surveillance Study
    Schenk, Jeannette M.
    Liu, Menghan
    Neuhouser, Marian L.
    Newcomb, Lisa F.
    Zheng, Yingye
    Zhu, Kehao
    Brooks, James D.
    Carroll, Peter R.
    Dash, Atreya
    Ellis, William J.
    Filson, Christopher P.
    Gleave, Martin E.
    Liss, Michael
    Martin, Frances M.
    Morgan, Todd M.
    Wagner, Andrew A.
    Lin, Daniel W.
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2023, 75 (02): : 618 - 626
  • [47] Multiparametric prostate MRI and MRI/ultrasound fusion biopsy as tools to follow prostate cancer progression for men on active surveillance
    Shakir, Nabeel
    Walton-Diaz, Annerleim
    Rais-Bahrami, Soroush
    Turkbey, Baris
    Rothwax, Jason
    Hong, Cheng William
    Stamatakis, Lambros
    George, Arvin
    Okoro, Chinonyerem
    Raskolnikov, Dima
    Siddiqui, Minhaj
    Su, Daniel
    Simon, Richard
    Wood, Bradford J.
    Choyke, Peter L.
    Pinto, Peter A.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [48] Why do men with prostate cancer discontinue active surveillance for definitive treatment? A mixed methods investigation
    McIntosh, Megan
    Opozda, Melissa J.
    O'Callaghan, Michael
    Vincent, Andrew D.
    Galvao, Daniel A.
    Short, Camille E.
    PSYCHO-ONCOLOGY, 2022, 31 (08) : 1420 - 1430
  • [49] Diet and Health-related Quality of Life Among Men on Active Surveillance for Early-stage Prostate Cancer: The Men's Eating and Living Study (Cancer and Leukemia Group 70807 [Alliance])
    Parsons, J. Kellogg
    Zahrieh, David
    Patel, Devin
    Mohler, James L.
    Chen, Ronald C.
    Paskett, Electra D.
    Liu, Heshan
    Peil, Elizabeth S.
    Rock, Cheryl L.
    Hahn, Olwen
    Taylor, John
    Van Veldhuizen, Peter J., Jr.
    Small, Eric J.
    Morris, Michael J.
    Naughton, Michelle J.
    Pierce, John P.
    Marshall, James
    EUROPEAN UROLOGY FOCUS, 2022, 8 (06): : 1607 - 1616
  • [50] Pathologic upgrading on confirmatory biopsy in a racially diverse group of men on active surveillance for prostate cancer.
    Feibus, Allison H.
    Haney, Nora M.
    Boxberger, John
    Levy, Justin
    Libby, Robert Scott
    Kramer, Jordan J.
    Ledet, Elisa M.
    Moparty, Krishnarao
    Thomas, Raju
    Lewis, Brian E.
    Silberstein, Jonathan L.
    Sartor, A. Oliver
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
12345